Results per Page:

Skin in the game: Changing the story of Merkel cell carcinoma
How the Nghiem Lab and its supporters are improving outcomes for patients with a rare cancer

Discovery of a hidden tumor suppressor in the genome of the virus that causes Merkel cell carcinoma
From the Galloway Lab, Human Biology Division

The Beam: Proton therapy for rare cancers, an in-depth look at our team coordinators’ role and meet new medical assistant
Proton therapy’s role in the treatment of less common cancer, learn what proton therapy coordinators do and an introduction to Jade Duke, MA

Here comes the sun! What’s your skin strategy?
Avoiding sunburn is the first step in preventing deadly skin cancer melanoma

New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Helps explain why only certain MCC patients respond to immune checkpoint inhibitors, could point toward new strategies to improve treatment responses

Macrophages predict response to immunotherapy in Merkel cell carcinoma
From the Nghiem lab, Fred Hutch Clinical Research Division & UW Dermatology

Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development

Two opposing “agendas” keep skin mutant cell clusters at an impasse
From the Beronja lab, Human Biology Division

Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer

Researchers identify new way skin stops tumor growth
‘Oncogene-induced differentiation’ joins two other strategies for counteracting potentially cancer-causing DNA changes

Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma
‘Incredibly big change’ in treatment of deadly skin cancer, new data show

7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health

Immunotherapy drug becomes first therapy approved by FDA for rare skin cancer
Benefit seen in nearly one-third of patients ‘with no hope at all of surviving’ their treatment-resistant Merkel cell carcinoma

Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma

Skin cancer: 9 things to know to lower your risk
From cover-ups to caffeine, here are some tips for protecting your skin during the summer and all year long

Tanning bed use declines, new study shows
Rate of use has dipped slightly but 10 million Americans are still using tanning salons regularly